HealthEquity (NASDAQ:HQY) Given “Buy” Rating at BTIG Research

BTIG Research reiterated their buy rating on shares of HealthEquity (NASDAQ:HQY) in a report published on Thursday morning,Benzinga reports. They currently have a $130.00 target price on the stock.

A number of other equities analysts also recently weighed in on HQY. Jefferies Financial Group lifted their target price on shares of HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research note on Wednesday, September 3rd. Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. KeyCorp dropped their price objective on HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 8th. Citizens Jmp raised their target price on HealthEquity from $117.00 to $122.00 and gave the stock a “market outperform” rating in a research note on Thursday. Finally, Citigroup reiterated an “outperform” rating on shares of HealthEquity in a report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $120.07.

HealthEquity Price Performance

HealthEquity stock opened at $95.67 on Thursday. The stock’s 50 day moving average is $96.41 and its 200 day moving average is $96.87. HealthEquity has a one year low of $74.07 and a one year high of $116.65. The firm has a market cap of $8.24 billion, a P/E ratio of 43.89, a P/E/G ratio of 1.42 and a beta of 0.18. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23.

HealthEquity (NASDAQ:HQY) last released its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. The business had revenue of $322.16 million during the quarter, compared to the consensus estimate of $320.92 million. HealthEquity had a net margin of 14.86% and a return on equity of 12.95%. The company’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.78 EPS. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, research analysts expect that HealthEquity will post 2.32 EPS for the current year.

Insider Activity at HealthEquity

In related news, EVP Delano Ladd sold 6,000 shares of the stock in a transaction on Friday, September 19th. The stock was sold at an average price of $94.11, for a total value of $564,660.00. Following the transaction, the executive vice president directly owned 79,456 shares in the company, valued at $7,477,604.16. This trade represents a 7.02% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael Henry Fiore sold 1,781 shares of HealthEquity stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the completion of the sale, the executive vice president directly owned 49,795 shares of the company’s stock, valued at approximately $4,392,416.95. The trade was a 3.45% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 10,781 shares of company stock worth $1,016,707. Corporate insiders own 1.50% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in HQY. Invesco Ltd. raised its position in HealthEquity by 50.6% in the 1st quarter. Invesco Ltd. now owns 2,446,198 shares of the company’s stock valued at $216,171,000 after buying an additional 821,425 shares during the last quarter. Norges Bank purchased a new position in HealthEquity during the 2nd quarter worth $75,072,000. Westfield Capital Management Co. LP grew its stake in shares of HealthEquity by 124.6% in the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock worth $132,543,000 after acquiring an additional 701,819 shares in the last quarter. AQR Capital Management LLC raised its holdings in shares of HealthEquity by 148.5% in the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after purchasing an additional 661,795 shares during the last quarter. Finally, Nuveen LLC bought a new position in shares of HealthEquity during the first quarter valued at about $53,076,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.